CirCode
About:
CirCode Bio is an innovative biotechnology company focusing on the development of circular RNA nucleic acid drugs.
Website: https://www.circodebio.com/
Top Investors: Johnson & Johnson Innovation – JJDC, K2VC, Kaitai Capital, EFung Capital, Kunlun Capital
Description:
CirCode Bio is an innovative biotechnology company focusing on the development of circular RNA nucleic acid drugs.
Total Funding Amount:
$20M
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2021-01-01
Contact Email:
info(AT)circodebio.com
Founders:
Zefeng Wang
Number of Employees:
Last Funding Date:
2023-08-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai